Relative Valuation Lab

Implied price gap for Merck & Co., Inc. vs Johnson & Johnson

Live view of SEC fundamentals with peer-based benchmarks and implied valuation gaps.

Implied price

Blend averages both multiples when available.

Current vs implied

Current

$108.83

Implied

$255.60

If Merck & Co., Inc. traded at Johnson & Johnson P/E multiple, the stock price would be $255.60 (vs $108.83).

134.9% ($146.77)

Implied from P/E

$255.60

Implied from P/S

$151.19

Implied price calculator

Apply the selected peer multiple to the target fundamentals.

Target company

MRK

Benchmark peer

JNJ

Merck & Co., Inc. fundamentals

Current price

$108.83

EPS (TTM)

6.74

Rev / share

25.40

Johnson & Johnson multiples

P/E multiple

37.92x

P/S multiple

5.95x

Growth vs value matrix

Bottom-right quadrant is the sweet spot: high growth, low valuation.

EV/Revenue vs growth

Smart diff metrics

Highlight the winner and flag when premiums are justified.

Metric	MRK	Delta vs JNJ	JNJ	Context
Revenue growth (LTM)	6.7%	56.8% higher	4.3%	Growth edge
Gross margin	76.3%	10.5% higher	69.1%	Pricing power
EBITDA margin	41.9%	55.8% higher	26.9%	Operating leverage
EV/Revenue	4.55x	25.6% lower	6.11x	Multiple discount
P/E	16.46x	56.6% lower	37.92x	Value edge
Net debt / EBITDA	0.4	27.0% lower	0.6	Lower leverage

Football field valuation

See where Merck & Co., Inc. trades vs valuation ranges.

Peer implied

$151.19 - $256.97

Historical band

$99.87 - $122.07

DCF range

$452.08 - $611.64

Value trap detector

Quality signals that explain why a cheap stock might stay cheap.

Piotroski F-Score

Financial strength (0-9).

Merck & Co., Inc.7/9

Partial coverage: 8/9 checks

Johnson & Johnson5/9

Altman Z-Score

Bankruptcy risk gauge.

Merck & Co., Inc.: not enough data yet.

Johnson & JohnsonSafe (5.06)

DistressGreySafe

Enterprise value bridge

Market cap + debt - cash = EV.

Enterprise value$291.7B

Market cap $280.3BDebt $25.1BCash -$13.7B

Risk factor diff (10-K Item 1A)

Unique risks that explain valuation discounts.

SEC text parsing is not configured yet. Connect 10-K text ingestion to compare Item 1A risk factors.

MD&A sentiment pulse

Tracks uncertainty language that often precedes multiple compression.

No MD&A sentiment data found. Enable the filing text analyzer to populate this chart.

MRK CIK: 310158

JNJ CIK: 200406

Relative Valuation Lab

Implied price gap for Merck & Co., Inc. vs Johnson & Johnson

Live view of SEC fundamentals with peer-based benchmarks and implied valuation gaps.

Implied price

Blend averages both multiples when available.

Current vs implied

Current

$108.83

Implied

$255.60

If Merck & Co., Inc. traded at Johnson & Johnson P/E multiple, the stock price would be $255.60 (vs $108.83).

134.9% ($146.77)

Implied from P/E

$255.60

Implied from P/S

$151.19

Implied price calculator

Apply the selected peer multiple to the target fundamentals.

Target company

MRK

Benchmark peer

JNJ

Merck & Co., Inc. fundamentals

Current price

$108.83

EPS (TTM)

6.74

Rev / share

25.40

Johnson & Johnson multiples

P/E multiple

37.92x

P/S multiple

5.95x

Growth vs value matrix

Bottom-right quadrant is the sweet spot: high growth, low valuation.

EV/Revenue vs growth

Smart diff metrics

Highlight the winner and flag when premiums are justified.

Metric	MRK	Delta vs JNJ	JNJ	Context
Revenue growth (LTM)	6.7%	56.8% higher	4.3%	Growth edge
Gross margin	76.3%	10.5% higher	69.1%	Pricing power
EBITDA margin	41.9%	55.8% higher	26.9%	Operating leverage
EV/Revenue	4.55x	25.6% lower	6.11x	Multiple discount
P/E	16.46x	56.6% lower	37.92x	Value edge
Net debt / EBITDA	0.4	27.0% lower	0.6	Lower leverage

Football field valuation

See where Merck & Co., Inc. trades vs valuation ranges.

Peer implied

$151.19 - $256.97

Historical band

$99.87 - $122.07

DCF range

$452.08 - $611.64

Value trap detector

Quality signals that explain why a cheap stock might stay cheap.

Piotroski F-Score

Financial strength (0-9).

Merck & Co., Inc.7/9

Partial coverage: 8/9 checks

Johnson & Johnson5/9

Altman Z-Score

Bankruptcy risk gauge.

Merck & Co., Inc.: not enough data yet.

Johnson & JohnsonSafe (5.06)

DistressGreySafe

Enterprise value bridge

Market cap + debt - cash = EV.

Enterprise value$291.7B

Market cap $280.3BDebt $25.1BCash -$13.7B

Risk factor diff (10-K Item 1A)

Unique risks that explain valuation discounts.

SEC text parsing is not configured yet. Connect 10-K text ingestion to compare Item 1A risk factors.

MD&A sentiment pulse

Tracks uncertainty language that often precedes multiple compression.

No MD&A sentiment data found. Enable the filing text analyzer to populate this chart.

MRK CIK: 310158

JNJ CIK: 200406